Skip to Content
Merck
  • Demyelination reduces brain parenchymal stiffness quantified in vivo by magnetic resonance elastography.

Demyelination reduces brain parenchymal stiffness quantified in vivo by magnetic resonance elastography.

Proceedings of the National Academy of Sciences of the United States of America (2012-04-12)
Katharina Schregel, Eva Wuerfel, Philippe Garteiser, Ines Gemeinhardt, Timour Prozorovski, Orhan Aktas, Hartmut Merz, Dirk Petersen, Jens Wuerfel, Ralph Sinkus
ABSTRACT

The detection of pathological tissue alterations by manual palpation is a simple but essential diagnostic tool, which has been applied by physicians since the beginnings of medicine. Recently, the virtual "palpation" of the brain has become feasible using magnetic resonance elastography, which quantifies biomechanical properties of the brain parenchyma by analyzing the propagation of externally elicited shear waves. However, the precise molecular and cellular patterns underlying changes of viscoelasticity measured by magnetic resonance elastography have not been investigated up to date. We assessed changes of viscoelasticity in a murine model of multiple sclerosis, inducing reversible demyelination by feeding the copper chelator cuprizone, and correlated our results with detailed histological analyses, comprising myelination, extracellular matrix alterations, immune cell infiltration and axonal damage. We show firstly that the magnitude of the complex shear modulus decreases with progressive demyelination and global extracellular matrix degradation, secondly that the loss modulus decreases faster than the dynamic modulus during the destruction of the corpus callosum, and finally that those processes are reversible after remyelination.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Bis(cyclohexanone)oxaldihydrazone, ≥95% (TLC)
Supelco
Bis(cyclohexanone)oxaldihydrazone, for spectrophotometric det. of Cu, ≥99.0%